Pharmaceuticals - Site Feedback

United States

P&G Network Search

Pharmaceuticals:
US Products

Consumers:

Health Care Professionals:

FDA APPROVES NEW ONCE-A-MONTH DOSE OF ACTONEL FOR POSTMENOPAUSAL OSTEOPOROSIS

CINCINNATI, Bridgewater, NJ, April 24, 2008 — The U.S. Food and Drug Administration (FDA) approved a new once-a-month dose (150 mg) of Actonel� (risedronate sodium) tablets for the treatment and prevention of postmenopausal osteoporosis. Actonel is approved to reduce the risk of fractures in postmenopausal women with osteoporosis.
More:

We Want to Hear From You

P&G Pharmaceuticals would like your help in making this site the most useful to you and other visitors. We would appreciate your time in answering a few brief questions.

This information will not be shared with other marketers without your consent. Your responses will only be used to evaluate the quality of the design and contents of the information presented. If you have already completed this questionnaire, please do not complete it again.

We thank you for your participation and value your input.

1.	Are you?
	Female
	Male

2.	What is your age?


3.	Are you a

4.	How did you find out about the P&G Pharmaceuticals Web site?


5.	What topics are of most interest to you? Check all that apply.
		Information about P&G Pharmaceuticals		Information about Research & Development
		Information about individual products		Job openings at P&G Pharmaceuticals
		Information about investing in P&G		Health News
		Information about Clinical Trials

6.	How many times have you visited this site?
	First time
	2-5 times
	6 times or more

7.	How often do you plan to return to this site? (If you're not familiar with this site, you may submit this survey now without answering the remaining questions.)


8.	What do you think of the information offered on this site, in general?


9.	What do you consider the most useful area on this site?


10.	What area do you think should be expanded or improved?
	P&GP Products		Clinical Trials
	About P&G Pharmaceuticals		Health News
	Investors		Other Resources
	Research & Development		No area needs improvement
	Career Center

11.	How likely would you recommend this site to another person who is interested in learning more about P&G Pharmaceuticals?




	©2008 Procter & Gamble. All claims valid only in the U.S. Legal Information Privacy Statement P&G Links